1. asheymommy
2. dynamichealthsol
3. badaleyes
4. franciscaguila78
5. marz11
1.dynamichealthsol 02/02/2018
Beats EPS estimates by $0.04.
2.badaleyes 02/02/2018
Big news - Sees FY18 revs $41.2-42.7 bln vs $41.10 bln
3.dynamichealthsol 01/03/2018
er details
4.marz11 04/10/2018
Merck monotherapy met primary endpoint in phase 3 keynote-042 study, significantly improving OS as first-line…
5.asheymommy 01/26/2018
today > $MRK - CHMP gave positive opinions for three medicines to treat type 2 diabetes: Segluromet (ertugliflozin / metform…
6.asheymommy 03/01/2018
7.asheymommy 02/15/2018
AstraZeneca and Merck
8.asheymommy 01/26/2018
News out. GL
9.dynamichealthsol 03/23/2018
Announced multiple receptor tyrosine kinase inhibitor LENVIMA has been approved in Japan for unresectable hep…
10.badaleyes 02/05/2018
Now is the time to get out
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW